Form 4: Lemaitre Vascular Inc. Executive Granted Stock Options and Restricted Stock Units
Executive Compensation Filing
Lemaitre Vascular Inc. has granted stock options and restricted stock units to executive John James O'Connor.
Summary
- Lemaitre Vascular Inc. granted John James O'Connor stock options to purchase 420 shares at $101.12 per share.
- These options vest over a three-year period, with 33 1/3% vesting on the first anniversary of the grant date and the remainder vesting in equal annual installments over the next two years.
- Additionally, O'Connor received 2,594 restricted stock units, which also vest over a three-year period.
- 33 1/3% of the restricted stock units vest on the first anniversary of the grant date, with the balance vesting in equal annual installments over the remaining two years.
- Both the stock options and restricted stock units were granted on December 6, 2024.
Sentiment
Score: 7
Explanation: The document reflects a standard corporate practice of incentivizing executives with equity, which is generally viewed positively. There are no indications of negative sentiment.
Positives
- The granting of stock options and restricted stock units aligns executive interests with those of shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Risks
- The value of the stock options is dependent on the future performance of the company's stock price.
- The vesting schedule may not fully align with the executive's performance.
Industry Context
The granting of stock options and restricted stock units is a common practice in the corporate world to incentivize and retain key executives.
Comparison to Industry Standards
- Stock option and restricted stock unit grants are standard practice for executive compensation across various industries, including medical device companies.
- Vesting schedules of three years are also common, aligning with typical long-term incentive plans.
- Companies like Medtronic and Boston Scientific also use similar equity-based compensation strategies to retain and motivate their executives.
Stakeholder Impact
- Shareholders may view the grants positively as they align executive interests with company performance.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 2024-12-06 | Grant date for stock options and restricted stock units. |
| 2024-12-10 | Date of filing signature. |
| 2029-12-06 | End of the vesting period for the stock options and restricted stock units. |
Keywords
stock options, restricted stock units, executive compensation, vesting, Lemaitre Vascular Inc., LMAT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.